Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl

   
Google
 
Web NewDrugInformation.com

Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl


Drug - Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl
The trade name of the product as shown on the labeling.

Dosage - GRANULE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Erythromycin Ethylsuccinate; Sulfisoxazole Acetyl
Multiple ingredients are in alphabetical order.

Strength - EQ 200MG BASE/5ML;EQ 600MG BASE/5ML
The potency of the active ingredient(s), Erythromycin Ethylsuccinate; Sulfisoxazole Acetyl. May repeat for multiple part products.

Applicant - BARR
The firm name holding legal responsibility for Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 062759
The FDA assigned number to Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 20, 1988
The date Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl is in. Format is RX, OTC, DISCN.

Applicant Full Name - Barr Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl.

Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl